Clinical Trials

Embolism, Neoplasms, Venous Thromboembolism

NCT07439991 2026-02-27

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Classical hematologyThoracic

900 enrolled

Disease, Lung Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT05171049 2026-02-23

ASTER

Phase 3 Terminated

1,150 enrolled

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07399977 2026-02-12

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

259 enrolled

Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

996 enrolled

Neoplasms, Venous Thromboembolism

NCT07310693 2025-12-30

CLOVER

500 enrolled

Venous Thromboembolism

NCT07270263 2025-12-26

HEM-DOAC

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

100 enrolled

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT07303816 2025-12-26

STAT-CAT

Phase 4 Not yet recruiting

4,000 enrolled

Phase 3 Active not recruiting

Neoplasms, Pulmonary Embolism, Venous Thromboembolism

NCT05171075 2025-12-19

MAGNOLIA

417 enrolled

Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07292376 2025-12-18

Implementing VTE Prevention in Ambulatory Cancer Care

Phase NA Enrolling by invitation

25 enrolled

Neoplasms, Venous Thromboembolism

NCT07288632 2025-12-17

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Classical hematologyThoracic

500 enrolled

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Phase 4 Enrolling by invitation

2,868 enrolled

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT06672250 2025-09-24

The Correlation Between Circulatory Tumor Cells and Venous Thrombosis

120 enrolled

Classical hematologyPlasma cell

Neoplastic Cells, Circulating, Neoplasms, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

108 enrolled

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT06451003 2025-07-31

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

30 enrolled

Phase 3 Not yet recruiting

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

530 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05920343 2025-07-10

PREVENT-GU

Phase 2/3 Recruiting

120 enrolled

Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Phase 3 Recruiting

1,828 enrolled

Neoplasms, Venous Thromboembolism

NCT06129760 2025-07-09

Glioblastoma Remote Monitoring and Care - Research Protocol

25 enrolled

CNSClassical hematology

Glioblastoma, Seizures, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

BreastClassical hematology

Venous Thromboembolism

NCT07008508 2025-06-06

BRAVE-Cyclin

Active not recruiting

300 enrolled

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Phase 4 Recruiting

330 enrolled

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT06952062 2025-05-04

CARDIO-COM

Active not recruiting

2,400 enrolled

Cardiovascular Diseases, Hemorrhage, Neoplasms, Venous Thromboembolism

NCT06950697 2025-04-30

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Classical hematologyThoracic

2,400 enrolled

Lung Neoplasms, Venous Thromboembolism

NCT06886516 2025-03-20

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

30 enrolled